CompaniesCerus Endovascular

Cerus Endovascular

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

7

As Collaborator

0

Total Enrollment

595

By Phase

NA: 4PHASE4: 1

By Status

COMPLETED: 2TERMINATED: 2RECRUITING: 1WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT02507531
NCT04187573
NCT04852783
NCT06693011
Hover over trial bars to see details

Recent Trials

NCT06693011Lead Sponsor
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
NARecruiting
250 participants
Started: Jun 10, 2025 · Completed: Jan 31, 2030
NCT04579081Lead Sponsor
Post Market Clinical Follow-up (PMCF)Study of the Contour Neurovascular SystemTM
N/AWithdrawn
Started: Dec 31, 2021 · Completed: Jun 30, 2023
NCT04852783Lead Sponsor
US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair
PHASE4Active, not recruiting
250 participants
Started: Aug 6, 2021 · Completed: Dec 31, 2029
NCT04187573Lead Sponsor
Coil Assisted Flow Diversion Safety and Performance Study
NACompleted
38 participants
Started: Jan 21, 2020 · Completed: Nov 1, 2023
NCT03680742Lead Sponsor
Contour Neurovascular System - European Pre-Market Unruptured Aneurysm
NACompleted
34 participants
Started: Sep 18, 2018 · Completed: Feb 2, 2021
View all 7 trials →
Funding History (4)
D/A
Aug 26, 2019
Filing
D/A
Aug 22, 2018
Filing
D
Jan 17, 2018
Filing
D
Jan 31, 2017
Filing
Related Companies
Stryker
acquired